The history of Viagra and its creator , copyright, presents a complex picture for cautious investors. While the iconic drug initially generated enormous revenues , its exclusivity has expired , leading to generic alternatives flooding the arena. This reduction in pricing presents a substantial obstacle for copyright and any fund considering a signi